What Happens If Your Pituitary Gland Is Removed?

Discover the significant impact of pituitary gland removal on the body’s master control system and the lifelong management required.

Removing the pituitary gland eliminates the body’s central hormonal command center, and without replacement therapy for every hormone it once produced, the consequences range from severe dehydration to fatal adrenal crisis within days. In practice, surgeons almost never remove the entire gland on purpose; the goal is usually to remove a tumor while preserving as much healthy tissue as possible. But when enough of the gland is lost or damaged, the downstream effects touch virtually every system in the body, because the pituitary’s hormones regulate the thyroid, the adrenal glands, growth, reproduction, and water balance. Living without a functioning pituitary is possible with modern medicine, but it requires a carefully managed cocktail of daily hormone replacements for life.

Why the Pituitary Gland Gets Removed in the First Place

The overwhelming majority of pituitary surgeries are performed to remove tumors. Pituitary tumors account for roughly 10 to 15 percent of all brain tumors, and more than 80 percent of those are pituitary adenomas, which are usually benign. Surgery is the first-line treatment when these adenomas grow large enough to compress the optic nerves or the optic chiasm, threatening vision. Functioning adenomas that pump out excess hormones (causing conditions like Cushing’s disease or acromegaly) and rarer malignancies like craniopharyngiomas also land patients in the operating room.

Most of these surgeries go through the nose. The transsphenoidal approach, which reaches the pituitary through the sphenoid sinus, has been refined over more than a century. The first successful transsphenoidal removal of a pituitary tumor was reported in 1906, and by the time Harvey Cushing adopted the technique he had operated on 231 tumors with a mortality rate of about 5.6 percent. Modern endoscopic versions of the procedure have pushed morbidity far lower. Still, surgeons walking through the skull base face real risks, including cerebrospinal fluid leaks, which become more likely with larger tumors, harder tumor texture, higher body mass index, and repeat operations.

Losing Control of Water Balance

One of the most immediate and dramatic consequences of pituitary damage is the loss of vasopressin, the hormone that tells your kidneys to hold onto water. Without it, the kidneys simply let water pass straight through. You can produce enormous volumes of dilute urine, sometimes liters per hour, and become dangerously dehydrated if fluids are not replaced. This condition, called central diabetes insipidus (now increasingly referred to as arginine vasopressin deficiency), can develop within hours of surgery.

The good news is that in many cases it is temporary. A large meta-analysis found that transient vasopressin deficiency occurs in about 17 percent of patients after transsphenoidal surgery, while permanent deficiency develops in only about 3 percent overall. The odds depend heavily on the type of tumor. For ordinary pituitary adenomas, the permanent rate is around 2 percent. For craniopharyngiomas, which tend to be more entangled with the pituitary stalk, the permanent rate jumps to about 30 percent.

Some patients experience a strange three-phase pattern after pituitary stalk injury. First, vasopressin release fails and they produce too much urine. Then, over the next few days, damaged neurons dump their stored vasopressin all at once, flipping the problem: the body retains too much water and sodium levels plummet, a potentially dangerous swing. Finally, the stored vasopressin runs out and the original water-wasting returns, sometimes permanently. Hospital teams watch for this triphasic pattern carefully in the days after surgery, because each phase requires a different treatment approach.

The Cortisol Problem

If there is a single hormone loss that makes pituitary removal acutely life-threatening, it is cortisol. The pituitary’s ACTH normally tells the adrenal glands to produce cortisol, which the body needs to maintain blood pressure, blood sugar, and the stress response. Without it, a serious infection, a bad injury, or even a stressful flight delay can spiral into adrenal crisis: plummeting blood pressure, shock, and potentially death if not treated within hours.

ACTH deficiency is common after pituitary surgery even when the gland is not fully removed. Data from a Swedish registry of patients with nonfunctioning pituitary adenomas found that about 29 percent were already ACTH-deficient before surgery, and that proportion rose to 38 percent a year afterward. Among those who were ACTH-sufficient going in, about a quarter developed new deficiency after the operation, and most of those remained deficient at the five-year mark. Recovery is possible but not guaranteed: roughly a quarter of those who were deficient before surgery recovered function afterward, while about three-quarters did not.

Patients with pituitary apoplexy, a sudden bleed or infarction inside a pituitary tumor, tend to fare worse. The rapid pressure spike inside the sella can irreversibly damage anterior pituitary tissue. One study found that ACTH deficiency rates were more than double in patients who had experienced apoplexy compared with those who had not, and recovery of ACTH function was markedly poorer even three years out.

Treatment for cortisol deficiency means taking hydrocortisone tablets every day, and carrying an emergency injection kit for situations where oral medication cannot be absorbed or the body needs a rapid surge. In an adrenal crisis, the standard emergency protocol is a 100 mg injection of hydrocortisone immediately, followed by sustained high-dose replacement until the crisis resolves. People living without pituitary ACTH function learn to “stress dose,” increasing their hydrocortisone before planned surgeries, during fevers, or when the body is under unusual strain.

Thyroid, Sex Hormones, and Growth Hormone

The pituitary does not just drive cortisol. It also sends thyroid-stimulating hormone (TSH) to the thyroid, gonadotropins (LH and FSH) to the ovaries or testes, and growth hormone to virtually every tissue. Lose the gland, and you lose them all.

Central hypothyroidism, the variety caused by pituitary failure rather than a thyroid problem, is trickier to manage than ordinary hypothyroidism. Normally, doctors adjust thyroid medication by watching TSH levels in the blood. But when the pituitary is gone or damaged, TSH is already low or absent regardless of thyroid status, so it cannot serve as a guide. Clinicians have to rely on measuring the thyroid hormones themselves and on how the patient feels, which makes dosing more of an art.

Loss of gonadotropins shuts down sex hormone production. In adults, that means low testosterone or estrogen, with all the downstream effects: loss of libido, bone thinning, fatigue, mood changes, and infertility. Spontaneous conception becomes impossible for women with panhypopituitarism, though pregnancy can still be achieved through gonadotropin injections that essentially bypass the missing pituitary signals and stimulate the ovaries directly. In men, testosterone replacement restores most symptoms but does not restore fertility on its own; that requires separate gonadotropin therapy if sperm production is desired.

Growth hormone deficiency in adults is subtler but real. Without it, body composition shifts toward more fat and less lean muscle, energy levels drop, bone density declines, and cholesterol profiles worsen. Recombinant growth hormone injections can reverse many of these changes and improve quality of life. Whether to prescribe growth hormone for adults remains a judgment call that involves weighing cost, injection burden, and the patient’s individual symptom profile.

Children Face Higher Stakes

When pituitary function is lost in childhood, the most conspicuous effect is on growth. Without growth hormone during the years when the skeleton is still developing, a child may end up far shorter than their genetic potential. Data on children with multiple pituitary hormone deficiency show that growth hormone replacement can bring adult height remarkably close to normal: one study found that children who started with a height deficit of nearly four standard deviations below the mean reached a normal adult height after treatment. Interestingly, starting treatment earlier did not change the final adult height achieved, but it did allow puberty to be induced at a more age-appropriate time, which matters for psychosocial development.

Puberty itself depends on pituitary gonadotropins. Children who lose pituitary function need carefully timed hormone replacement to trigger and sustain pubertal development. The optimal regimens for inducing puberty in boys and girls with pituitary failure remain a clinical challenge, with limited comparative data to guide decisions. Getting the timing and dosing right has implications beyond the obvious physical ones: delayed or absent puberty affects self-image, peer relationships, and bone health.

Cognition, Fatigue, and Quality of Life

Beyond the measurable hormonal deficits, many patients report feeling cognitively foggy, chronically tired, and generally diminished for months or years after pituitary surgery. A prospective study tracking patients from before surgery through twelve months afterward found that overall cognitive function was largely unchanged, with some improvement in attention, and that self-reported fatigue actually improved in the first year. That sounds reassuring, but longer-term data paint a more mixed picture: many patients face persistent cognitive deficits, chronic fatigue, and diminished quality of life years after surgery.

What drives these persistent complaints is not entirely clear. Part of it is probably the difficulty of perfectly replacing hormones that in a healthy person are released in precise pulses and circadian rhythms. A daily hydrocortisone pill at 7 a.m. and noon is a rough approximation of a system that in health peaks before dawn and adjusts continuously throughout the day. Part of it may also involve oxytocin, a posterior pituitary hormone that rarely gets replaced. Recent research suggests that oxytocin deficiency may contribute to social dysfunction, anxiety, and reduced well-being in patients with pituitary disease, though measuring oxytocin reliably enough to diagnose a deficiency remains a challenge.

Mortality and Long-Term Health Risks

People living with hypopituitarism die earlier than the general population, on average. A landmark study found that overall mortality was about 73 percent higher than expected for age- and sex-matched controls, with women facing a somewhat greater excess risk than men. An earlier study had pointed to cardiovascular disease as a major driver, reporting that deaths from vascular disorders were roughly double what would be expected and suggesting that growth hormone deficiency might be a contributing factor. Later data, however, suggested the cardiovascular contribution was real but not as dominant as originally thought, and that the excess mortality is probably driven by multiple factors, including suboptimal hormone replacement, increased infection risk during periods of cortisol deficiency, and metabolic disturbances from growth hormone loss.

Whether modern growth hormone replacement and more refined cortisol dosing strategies have narrowed this mortality gap is an active area of research. The data are encouraging in some cohorts but far from settled. What is clear is that close, lifelong endocrine follow-up matters enormously. Hormone replacement needs to be individualized and adjusted over time, because underdosing and overdosing both carry risks.

What Daily Life Actually Looks Like

For someone living without meaningful pituitary function, the morning routine involves a small pharmacy. A typical regimen might include hydrocortisone two or three times a day (timed to mimic cortisol’s natural rhythm as best as possible), levothyroxine for thyroid replacement, testosterone or estrogen, and sometimes desmopressin (a synthetic vasopressin) to keep fluid balance in check. Growth hormone, if prescribed, is a daily subcutaneous injection, usually given at bedtime.

Beyond the pills and injections, there is a constant awareness of vulnerability. A stomach bug that causes vomiting can prevent hydrocortisone absorption and trigger an adrenal crisis. International travel means carrying emergency injection kits through airport security and planning around time-zone shifts that disrupt dosing schedules. Vigorous exercise requires forethought about hydration and cortisol coverage. Patients are typically advised to carry a standardized emergency card and to educate the people around them on how to administer an emergency hydrocortisone injection if they become unconscious.

Pregnancies in women with panhypopituitarism are high-risk by definition, requiring fertility specialists to induce ovulation and endocrinologists to adjust every hormone replacement throughout gestation. The cortisol requirement rises during pregnancy, the thyroid dose often needs to increase, and labor and delivery demand careful stress-dose glucocorticoid coverage.

The Financial Burden

Living without a pituitary gland is expensive. A Swedish study found that patients with hypopituitarism incurred nearly double the direct healthcare costs of the general population, driven largely by inpatient care, and that excess total costs amounted to roughly 35,800 Swedish crowns per patient per year. The rate of disability pension among working-age patients was about twice the expected rate, and sick leave was significantly higher. Growth hormone replacement adds substantially to the tab: patients receiving it had annual healthcare costs of roughly €9,300 compared to about €6,800 for those not on growth hormone, with the difference driven almost entirely by the drug cost. In the United States, a claims-database analysis found that patients with a high likelihood of adult growth hormone deficiency had mean monthly medical costs of about $1,845, roughly four times those in a low-likelihood comparison group.

How Early Pituitary Science Was Built

The question of whether you can survive without a pituitary gland has a surprisingly gory experimental history. In the late 1800s and early 1900s, researchers removed pituitaries from cats and dogs through lateral skull openings to determine whether the gland was essential for life. The answer, they eventually learned, was that animals could survive total hypophysectomy, but only with careful supportive care. Those experiments mapped the downstream effects of each lost hormone axis long before replacement therapies existed, and they directly informed the surgical techniques that were later adapted for human patients. The transition from killing the gland to preserve it as much as possible, removing only what is truly necessary, has been the dominant trajectory of pituitary surgery ever since.